C-CAMP serves as a global hub for deep-tech-driven breakthroughs

26 Aug 2022 , 08:07 AM

In the expanding biotechnology industry, a number of businesses nurtured at Bengaluru’s Centre for Cellular and Molecular Platforms (C-CAMP) may soon become unicorns, or companies valued at $1 billion or more.

They span every significant deep-tech area, from the discovery of antibiotics to immuno-oncotherapy, stem cell therapy to tissue engineering, molecular diagnostics to sustainable green technologies.

One of India’s largest biotech ecosystems, C-CAMP serves as a global hub for deeptech-driven breakthroughs.

Seven of its renowned deep-science businesses raised more than $70 million, or Rs550 crore, in the most recent quarter through series A and series B investments as well as acquisitions, for a combined valuation of more than $250 million (Rs 2,000 crore).

For almost ten years, C-CAMP has sponsored companies like Bugworks, Sea6 Energy, String Bio, Eyestem, Pandorum, Achira, and Zumutor.

For feedback and suggestions, write to us at [e-mail]